Founder and CEO of US online social media and social networking service Facebook Mark Zuckerberg. Photo by KENZO TRIBOUILLARD/AFP via Getty Images/FILE)
Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments.
The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.
“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”
The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well.
The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies.
The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19.
The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb.
The second-largest stablecoin, USDC, backed by the company Circle recently received a $400 million funding infusion from traditional financial firms like BlackRock and Fidelity even as crypto reels from more high profile heists.
A group of Tesla shareholders suing CEO Elon Musk over some 2018 tweets about taking the company private is asking a federal judge to order Musk to stop commenting on the case.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Between Bells executive producer Conor White recaps some of the biggest stories of the week, and teaches Azia Celestino and Hena Doba a thing or two at the same time. It's This Week In Trivia!
Josh Thorngren, vice president of growth at the cybersecurity company Torq, joined Cheddar News to talk about staffing shortages hitting his industry, and what he thinks is behind it. "Over 70 percent of cybersecurity professionals say they're unhealthily stressed, and it's stress because we only talk about them when they failed," he said. "That makes the job harder day in and day out, and so it's not just a how do we keep up with the rising challenge, it's how do we actually retain folks who are in these positions today." Thorngren also stated that cybersecurity needs to transform into a less technical field in order to appeal to a bigger group of potential workers.
Twitter said in a statement Friday that its board of directors has unanimously adopted a “poison pill” defense in response to Tesla CEO Elon Musk’s proposal to buy the company and take it private.
The Food and Drug Administration has issued an emergency use authorization for what it says is the first device that can detect COVID-19 in breath samples.
Catching you up on what you need to know on April 15, 2022, with four of the victims from the Brooklyn subway shooting still hospitalized as the suspect is held without bail, Russia resumes attacks on Kyiv, teachers across the country receive their largest pay raises in decades, and more.
